Cargando…
A Malaria Vaccine That Elicits in Humans Antibodies Able to Kill Plasmodium falciparum
BACKGROUND: Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was identified, characterised, and developed based on a unique immuno-clinical approach. The vaccine construct was derived from regions fully conserved among various strains and containing B cell epitop...
Autores principales: | Druilhe, Pierre, Spertini, François, Soesoe, Daw, Corradin, Giampietro, Mejia, Pedro, Singh, Subhash, Audran, Regine, Bouzidi, Ahmed, Oeuvray, Claude, Roussilhon, Christian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277929/ https://www.ncbi.nlm.nih.gov/pubmed/16262450 http://dx.doi.org/10.1371/journal.pmed.0020344 |
Ejemplares similares
-
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages
por: Bouharoun-Tayoun, Hasnaa, et al.
Publicado: (2015) -
The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial
por: Audran, Régine, et al.
Publicado: (2009) -
Human Malaria in Immunocompromised Mice: An in Vivo Model to Study Defense Mechanisms against Plasmodium falciparum
por: Badell, Edgar, et al.
Publicado: (2000) -
Understanding Human-Plasmodium falciparum Immune Interactions Uncovers the Immunological Role of Worms
por: Roussilhon, Christian, et al.
Publicado: (2010) -
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine
por: Ayadi, Imen, et al.
Publicado: (2020)